Viral rebound uncommon after molnupiravir, nirmatrelvir-ritonavir therapy
Dec 09, 2022
Viral rebound was uncommon with treatment for patients hospitalized with COVID-19 and not associated with increased mortality.
Paxlovid soon will not be free for Americans
Dec 07, 2022
At this point, about 6 million Americans have taken free Paxlovid doses.
Study explores impact of FDA approval of aducanumab on trial participation
Dec 06, 2022
Individuals who were independently aware of the FDA decision demonstrated a reduced willingness to participate.
Review links hearing aid devices with reduced cognitive decline
Dec 06, 2022
Further, the use of devices is linked to a 3% improvement in cognitive test scores in the short term.
Feds urge vaccination as ‘tripledemic’ hits more Americans
Dec 05, 2022
Vaccination will be key to keeping patients healthy through the winter holidays.
Subjective cognitive decline tied to incident dementia in Black, Latinx individuals
Dec 01, 2022
Subjective cognitive decline was associated with increased rates of incident dementia over time in the multiracial population, Latinx and non-Latinx Black individuals.
Lecanemab reduced markers of amyloid in early Alzheimer’s disease
Dec 01, 2022
Moderately less decline was seen in cognition and function at 18 months with lecanemab versus placebo.
Overactive bladder common in postacute COVID-19 syndrome
Nov 30, 2022
COVID-19 may lead to new or worsening urinary symptoms in men and women.
New COVID-19 variant XBB gaining ground among Americans
Nov 28, 2022
The new omicron subvariant is taking hold in the United States, health officials say, although it does not look more severe than its predecessors.
CDC: Flu has started early and with a punch
Nov 21, 2022
The United States already has seen 38,000 hospitalizations for flu; hospitals also are treating high numbers of patients with RSV and COVID-19.